We provide you with 20 years of free, institutional-grade data for VKTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VKTX. Explore the full financial landscape of VKTX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-23 | 1607678 | VKTX | 10-Q | Url |
| 2025-04-24 | 1607678 | VKTX | 10-Q | Url |
| 2025-02-26 | 1607678 | VKTX | 10-K | Url |
| 2024-10-23 | 1607678 | VKTX | 10-Q | Url |
| 2024-07-24 | 1607678 | VKTX | 10-Q | Url |
| 2024-04-25 | 1607678 | VKTX | 10-Q | Url |
| 2024-02-07 | 1607678 | VKTX | 10-K | Url |
| 2023-10-25 | 1607678 | VKTX | 10-Q | Url |
| 2023-07-26 | 1607678 | VKTX | 10-Q | Url |
| 2023-04-26 | 1607678 | VKTX | 10-Q | Url |
| 2023-02-10 | 1607678 | VKTX | 10-K | Url |
| 2022-10-26 | 1607678 | VKTX | 10-Q | Url |
| 2022-07-27 | 1607678 | VKTX | 10-Q | Url |
| 2022-04-27 | 1607678 | VKTX | 10-Q | Url |
| 2022-02-09 | 1607678 | VKTX | 10-K | Url |
| 2021-11-03 | 1607678 | VKTX | 10-Q | Url |
| 2021-07-28 | 1607678 | VKTX | 10-Q | Url |
| 2021-04-28 | 1607678 | VKTX | 10-Q | Url |
| 2021-02-17 | 1607678 | VKTX | 10-K | Url |
| 2020-10-28 | 1607678 | VKTX | 10-Q | Url |
| 2020-07-29 | 1607678 | VKTX | 10-Q | Url |
| 2020-04-30 | 1607678 | VKTX | 10-Q | Url |
| 2020-02-26 | 1607678 | VKTX | 10-K | Url |
| 2019-11-05 | 1607678 | VKTX | 10-Q | Url |
| 2019-08-01 | 1607678 | VKTX | 10-Q | Url |
| 2019-05-02 | 1607678 | VKTX | 10-Q | Url |
| 2019-03-13 | 1607678 | VKTX | 10-K | Url |
| 2018-11-07 | 1607678 | VKTX | 10-Q | Url |
| 2018-08-09 | 1607678 | VKTX | 10-Q | Url |
| 2018-05-09 | 1607678 | VKTX | 10-Q | Url |
| 2018-03-07 | 1607678 | VKTX | 10-K | Url |
| 2017-12-20 | 1607678 | VKTX | S-1 | Url |
| 2017-11-08 | 1607678 | VKTX | 10-Q | Url |
| 2017-10-17 | 1607678 | VKTX | S-1 | Url |
| 2017-08-09 | 1607678 | VKTX | 10-Q | Url |
| 2017-05-10 | 1607678 | VKTX | 10-Q | Url |
| 2017-03-21 | 1607678 | VKTX | 10-K | Url |
| 2016-11-10 | 1607678 | VKTX | 10-Q | Url |
| 2016-09-02 | 1607678 | VKTX | S-1 | Url |
| 2016-08-11 | 1607678 | VKTX | 10-Q | Url |
| 2016-05-10 | 1607678 | VKTX | 10-Q | Url |
| 2016-03-08 | 1607678 | VKTX | 10-K | Url |
| 2015-11-24 | 1607678 | VKTX | S-1 | Url |
| 2015-11-05 | 1607678 | VKTX | 10-Q | Url |
| 2015-08-14 | 1607678 | VKTX | 10-Q | Url |
| 2015-06-12 | 1607678 | VKTX | 10-Q | Url |
| 2014-07-01 | 1607678 | VKTX | S-1 | Url |
Viking Therapeutics, Inc(NASDAQ:VKTX) 
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR), ...
Website: http://www.vikingtherapeutics.com
Founded: 2012
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VKTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.